SCOLR starts studies
This article was originally published in The Tan Sheet
Executive Summary
SCOLR Pharma announces Nov. 1 the start of the first of three trials to evaluate the safety and efficacy of its OTC 12-hour CDT-based ibuprofen. The Bellevue, Wash.-based firm expects to complete the trials of its controlled delivery technology ibuprofen by the end of the first quarter of 2008, and plans to file a new drug application in the second half of 2008...